ArticleeLife2025
Temporal dynamics of viral fitness and the adaptive immune response in HCV infection.
Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The interplay between recovery and immunity in infectious and non-communicable diseases.Frontiers in cellular and infection microbiology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Numerous studies have shown that viral variants that elude the host immune response may incur a fitness expense, diminishing the survival of the viral strain within the host, and the capacity of the variant to survive future transmission events. This definition can be divided into intrinsic fitness-fitness without immune pressure-and effective fitness, which includes immune influence. Co-occurring mutations outside immune-targeted epitope regions may also affect variant survival (epistasis). Analysis of viral fitness and epistasis over the non-structural protein regions is lacking for hepatitis C virus (HCV). Using a rare cohort of subjects recently infected with HCV, we build on prior work by integrating mathematical modeling and experimental data to examine the interplay between transmitted/founder (T/F) viruses, immune responses, fitness, and co-occurring mutations. We show that viral fitness declines during the first 90 days post-infection (DPI), associated with the magnitude of CD8 +T cell responses and early diversification. Fitness then rebounds in a complex pattern marked by co-occurring mutations. Finally, we demonstrate that an early, strong CD8 +T cell response in the absence of neutralizing antibodies (nAbs) exerts strong selective pressure, allowing escape and chronic infection. These insights support HCV vaccine strategies that elicit broad T and B cell immunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.